Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,303 | -6,207 | -4,950 | -2,638 | -4,822 |
| Depreciation Amortization | 105 | 66 | 36 | 18 | 75 |
| Accounts payable and accrued liabilities | -308 | -729 | -330 | 121 | 980 |
| Other Working Capital | 220 | -1,058 | -862 | -534 | 887 |
| Other Operating Activity | 974 | 1,199 | 666 | 85 | -826 |
| Operating Cash Flow | $-8,312 | $-6,729 | $-5,440 | $-2,948 | $-3,706 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,842 | -3,266 | N/A | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | N/A | -2 |
| Investing Cash Flow | $-3,842 | $-3,266 | $N/A | $N/A | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 350 | 350 | 350 | 350 | 61 |
| Debt Repayment | -106 | -83 | -62 | -34 | -65 |
| Common Stock Issued | 15,503 | 15,503 | 15,503 | 15,503 | N/A |
| Financing Cash Flow | $15,747 | $15,770 | $15,791 | $15,819 | $-4 |
| Beginning Cash Position | 109 | 109 | 109 | 109 | 3,821 |
| End Cash Position | 3,702 | 5,884 | 10,460 | 12,980 | 109 |
| Net Cash Flow | $3,593 | $5,775 | $10,351 | $12,871 | $-3,712 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,312 | -6,729 | -5,440 | -2,948 | -3,706 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -2 |
| Free Cash Flow | -8,312 | -6,729 | -5,440 | -2,948 | -3,708 |